Mendaera, a San Mateo, CA-based healthcare technology company developing a handheld robotic interventional platform, raised $73M in Series B funding.
The round was led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health).
The company intends to use the funds to further enhance its efforts to scale robotics and AI across mainstream medical procedures.
Led by CEO and Founder Josh DeFonzo, Mendaera is providing innovations in medical robotics, making technologies readily available for these foundational everyday procedures. Its handheld interventional platform includes robotics, AI, real-time imaging, and virtual connectivity, and is designed to be accessible across specialties and sites of service to empower providers and systems to meet the demand for needle-based interventions.
Earlier this year, Mendaera announced that it had acquired the telepresence technology of Avail Medsystems to expand its portfolio to include virtual connectivity. In 2023, Mendaera announced a commercial agreement with the point-of-care ultrasound company Butterfly Network.
FinSMEs
26/09/2024